Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Isenberg

Showing results (11-20 of 280) with videos related to

Pageof 28
Sort By:
European Journal of Clinical Investigation|May 21, 2010
Primary Sjögren's syndrome activity and damage indices comparisonAna Campar, David A Isenberg
Clinical Immunology (Orlando, Fla.)|May 7, 2013
Reprint of: B cell elimination in systemic lupus erythematosus. Clin. Immunol. 146(2) 90-103João Furtado, David A Isenberg
British Journal of Hospital Medicine (London, England : 2005)|April 15, 2014
Is the age of eponymous diseases in rheumatology over?Sabrina Valentino, David A Isenberg
Expert Opinion on Biological Therapy|January 7, 2014
Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapiesZozik Fattah, David A Isenberg
Lupus|April 17, 2025
Baby you can drive my CAR-T cellsDaniela Garelick, David A Isenberg
Lupus|January 18, 2021
Rituximab - The first twenty yearsMaria Leandro, David A Isenberg
Rheumatology (Oxford, England)|July 2, 2024
Reflections on central nervous system lupusJoana Moutinho, David A Isenberg
Clinical and Experimental Rheumatology|April 27, 2019
Present and novel biologic drugs in primary Sjögren's syndromeSerena Fasano, David A Isenberg
Current Opinion in Rheumatology|September 5, 2020
Biologic therapies for systemic lupus erythematosus: where are we now?Grainne Murphy, David A Isenberg
Nature Reviews. Rheumatology|June 6, 2019
New therapies for systemic lupus erythematosus - past imperfect, future tenseGrainne Murphy, David A Isenberg
Pageof 28

Showing results (11-20 of 280) with videos related to

Sort By:
Pageof 28
European Journal of Clinical Investigation|May 21, 2010
Primary Sjögren's syndrome activity and damage indices comparisonAna Campar, David A Isenberg
Clinical Immunology (Orlando, Fla.)|May 7, 2013
Reprint of: B cell elimination in systemic lupus erythematosus. Clin. Immunol. 146(2) 90-103João Furtado, David A Isenberg
British Journal of Hospital Medicine (London, England : 2005)|April 15, 2014
Is the age of eponymous diseases in rheumatology over?Sabrina Valentino, David A Isenberg
Expert Opinion on Biological Therapy|January 7, 2014
Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapiesZozik Fattah, David A Isenberg
Lupus|April 17, 2025
Baby you can drive my CAR-T cellsDaniela Garelick, David A Isenberg
Lupus|January 18, 2021
Rituximab - The first twenty yearsMaria Leandro, David A Isenberg
Rheumatology (Oxford, England)|July 2, 2024
Reflections on central nervous system lupusJoana Moutinho, David A Isenberg
Clinical and Experimental Rheumatology|April 27, 2019
Present and novel biologic drugs in primary Sjögren's syndromeSerena Fasano, David A Isenberg
Current Opinion in Rheumatology|September 5, 2020
Biologic therapies for systemic lupus erythematosus: where are we now?Grainne Murphy, David A Isenberg
Nature Reviews. Rheumatology|June 6, 2019
New therapies for systemic lupus erythematosus - past imperfect, future tenseGrainne Murphy, David A Isenberg
Pageof 28